Form 4: Semler Scientific Director Daniel Messina Acquires Stock Options
SEC Form 4 Filing
Director Daniel Messina acquired stock options in Semler Scientific, Inc. on January 6, 2025.
Summary
- On January 6, 2025, Daniel S Messina, a director of Semler Scientific, Inc., acquired stock options.
- The options grant Messina the right to buy 6,875 shares of common stock at an exercise price of $58.94.
- The options vest monthly over one year, starting on the grant date, and expire on January 6, 2035.
- Following the transaction, Messina directly owns 6,875 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. The director's confidence is a slight positive.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, transact in their company's stock. These filings provide transparency to the market.
Stakeholder Impact
- The acquisition of stock options by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/06/2025 | Date of stock option grant and transaction. |
| 01/06/2035 | Expiration date of the stock options. |
| 01/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.